Details for New Drug Application (NDA): 062411
✉ Email this page to a colleague
NDA 062411 describes DEXASPORIN, which is a drug marketed by Pharmafair and Bausch And Lomb and is included in three NDAs. It is available from eight suppliers. Additional details are available on the DEXASPORIN profile page.
The generic ingredient in DEXASPORIN is dexamethasone; neomycin sulfate; polymyxin b sulfate. There are thirty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dexamethasone; neomycin sulfate; polymyxin b sulfate profile page.
The generic ingredient in DEXASPORIN is dexamethasone; neomycin sulfate; polymyxin b sulfate. There are thirty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dexamethasone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 062411
| Tradename: | DEXASPORIN |
| Applicant: | Pharmafair |
| Ingredient: | dexamethasone; neomycin sulfate; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM | ||||
| Approval Date: | May 16, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
